BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 24119413)

  • 1. Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease.
    Korish AA; Arafah MM
    BMC Complement Altern Med; 2013 Oct; 13():264. PubMed ID: 24119413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Camel milk ameliorates hyperglycaemia and oxidative damage in type-1 diabetic experimental rats.
    Meena S; Rajput YS; Pandey AK; Sharma R; Singh R
    J Dairy Res; 2016 Aug; 83(3):412-9. PubMed ID: 27600979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effect of curcumin on inflammation, oxidative stress and insulin resistance in high-fat fed obese rats.
    Maithilikarpagaselvi N; Sridhar MG; Swaminathan RP; Sripradha R
    J Complement Integr Med; 2016 Jun; 13(2):137-43. PubMed ID: 26845728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levocetirizine ameliorates high fructose diet-induced insulin resistance, vascular dysfunction and hepatic steatosis in rats.
    Shawky NM; Shehatou GS; Abdel Rahim M; Suddek GM; Gameil NM
    Eur J Pharmacol; 2014 Oct; 740():353-63. PubMed ID: 25064340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis.
    Wang L; Meng X; Zhang F
    J Med Food; 2012 May; 15(5):495-503. PubMed ID: 22551412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats.
    Al Zarzour RH; Ahmad M; Asmawi MZ; Kaur G; Saeed MAA; Al-Mansoub MA; Saghir SAM; Usman NS; Al-Dulaimi DW; Yam MF
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28718838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease.
    Parker A; Kim Y
    Metab Syndr Relat Disord; 2019 Oct; 17(8):389-396. PubMed ID: 31305201
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Nofal AE; AboShabaan HS; Fadda WA; Ereba RE; Elsharkawy SM; Hathout HM
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
    Krishnan A; Abdullah TS; Mounajjed T; Hartono S; McConico A; White T; LeBrasseur N; Lanza I; Nair S; Gores G; Charlton M
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G666-G680. PubMed ID: 28232454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease.
    Jung JH; Kim HS
    Food Chem Toxicol; 2013 Oct; 60():404-12. PubMed ID: 23900008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and Evaluation of Functional Foods for Prevention of Non-alcoholic Fatty Liver Disease.
    A Mohamed D; S Abdelgayed S; A Essa H; S Mohamed R
    Pak J Biol Sci; 2018 Jan; 21(9):454-462. PubMed ID: 30724047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water extract from artichoke ameliorates high-fat diet-induced non-alcoholic fatty liver disease in rats.
    Deng A; Liu F; Tang X; Wang Y; Xie P; Yang Q; Xiao B
    BMC Complement Med Ther; 2022 Nov; 22(1):308. PubMed ID: 36424606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
    Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
    Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transcutaneous electrical stimulation of lower limb muscles on experimental fatty liver.
    El-Kafoury BM; Seif AA; El-Aziz Abd El-Hady EA; El-Sebaiee AE
    Arab J Gastroenterol; 2016 Mar; 17(1):20-8. PubMed ID: 27067922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin.
    Alfarisi HAH; Ibrahim MB; Mohamed ZBH; Azahari N; Hamdan AHB; Che Mohamad CA
    ScientificWorldJournal; 2020; 2020():4503253. PubMed ID: 33132768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antidiabetic action of camel milk in experimental type 2 diabetes mellitus: an overview on the changes in incretin hormones, insulin resistance, and inflammatory cytokines.
    Korish AA
    Horm Metab Res; 2014 Jun; 46(6):404-11. PubMed ID: 24627103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary d-limonene alleviates insulin resistance and oxidative stress-induced liver injury in high-fat diet and L-NAME-treated rats.
    Victor Antony Santiago J; Jayachitra J; Shenbagam M; Nalini N
    Eur J Nutr; 2012 Feb; 51(1):57-68. PubMed ID: 21445622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxycitric acid ameliorates high-fructose-induced redox imbalance and activation of stress sensitive kinases in male Wistar rats.
    Sripradha R; Sridhar MG; Maithilikarpagaselvi N
    J Basic Clin Physiol Pharmacol; 2016 Jun; 27(4):349-56. PubMed ID: 26974136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
    Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
    Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.